Markets
markets

Allbirds traded more than JPMorgan and Exxon Mobil yesterday

After a surprising announcement that the tech bro shoemaker would be pivoting to AI on Wednesday, shares of Allbirds were flying high — soaring nearly 600% by the end of the day in record trading volume.

This was, for many reasons, completely insane.

Flipping the BIRD

Before the latest pop, Allbirds had a miniscule market cap of some ~$22 million. Yesterday, some $3.8 billion changed hands in BIRD — with the company’s market cap ending the session at a still small $148 million.

That means that the company turned over more than 25x its market cap in trading volume. Indeed, there were no other stocks with a market cap less than $1 billion that traded more than $1 billion yesterday — something of an outlier, to say the least.

Allbirds trading volume
Sherwood News

Two of the stocks that Allbirds out-traded were none other than the world’s largest bank (JPMorgan) and America’s largest oil company (Exxon Mobil), which only turned over $3 billion and $2.3 billion, respectively. And those weren’t even particularly low-volume days for those two corporate giants — Allbirds’ insane activity was way ahead of the average of the last 120 days for each.

Sole searching

Though this was perhaps more of a meme stock story than an AI story, those two worlds are starting to overlap, as retail traders have bought up anything adjacent to AI — particularly in the last couple of weeks, as risk-on assets have ripped higher since geopolitical risks have (seemingly) abated and indexes are back to all-time highs.

Of course, we’ve seen this movie before: remember Algorhythm Holdings, a former karaoke maker turned AI trucking logistics company, which obliterated the freight industry only a few months ago? Then there was the Long Island Iced Tea Corp., which, naturally, got into the blockchain.

Allbirds’ latest pivot, with a “long-term vision to become a fully integrated GPU-as-a-Service (GPUaaS) and AI-native cloud solutions provider,” which will be funded with its new $50 million convertible financing facility, is unlikely to concern neocloud leaders like CoreWeave, which is planning to spend $30 billion in 2026.

More Markets

See all Markets
markets

Low-cost airlines climb amid report that Spirit Airlines could liquidate as soon as this week

Shares of low-cost US airlines Frontier and JetBlue are up more than 3% in premarket trading following a Wednesday evening report that rival Spirit Airlines could liquidate as early as this week.

Spirit, which has made efforts to emerge from its bankruptcy filed in August, has reportedly been pummeled by elevated jet fuel prices.

JetBlue reached a deal to acquire Spirit in 2022, but it was blocked in 2024 on antitrust grounds. Bloomberg reported that Frontier had been in talks to merge with Spirit in December.

Jet fuel prices have squeezed the industry since the days leading up to the war in Iran. This month, most major US carriers hiked their bag fees in an attempt to offset some of the cost.

Lower oil prices are also moderately boosting airline stocks on Thursday morning. West Texas Intermediate crude futures were down about 3% as of 8:30 a.m. ET.

JetBlue reached a deal to acquire Spirit in 2022, but it was blocked in 2024 on antitrust grounds. Bloomberg reported that Frontier had been in talks to merge with Spirit in December.

Jet fuel prices have squeezed the industry since the days leading up to the war in Iran. This month, most major US carriers hiked their bag fees in an attempt to offset some of the cost.

Lower oil prices are also moderately boosting airline stocks on Thursday morning. West Texas Intermediate crude futures were down about 3% as of 8:30 a.m. ET.

markets

Hims jumps after RFK Jr. announces FDA may loosen regulations for 12 peptides

Hims & Hers rose more than 13% on Wednesday and continued to rise in premarket trading on Thursday after Health Secretary Robert F. Kennedy Jr. said that the Food and Drug Administration may ease restrictions on 12 peptides.

The move would allow compounding pharmacies to dispense the list of peptides, which have grown in popularity but are currently available only through suppliers who sell them for research purposes.

Hims and other consumer health companies have positioned themselves to begin selling peptides after getting the FDA nod.

Hims and other consumer health companies have positioned themselves to begin selling peptides after getting the FDA nod.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.